Hikma has a security interest in the Unifill, Nexus, and Allure PFS line:
"Hikma Pharmaceuticals LLC (“Hikma”) holds a security interest in the license rights granted under the Binding License, Development and Supply Agreement dated November 18, 2013, and Supply and Quality Agreement dated September 15, 2014, between Hikma and Unilife Medical to the Unifill®, Unifill Nexus™ and Unifill Allure™ syringes."
Page 91 of the 2Q 10Q.
- Forums
- ASX - By Stock
- UNS
- Ann: Appendix 4D
Ann: Appendix 4D, page-11
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)